SC
AGTC

Shay Capital’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Shay Capital’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,000
Closed -$39K – 559
2022
Q2 		$39K Hold
50,000
– – 0.01% 378
2022
Q1 		$54K Buy
+50,000
New +$90.9K 0.01% 448

Other funds holding AGTC

PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Shay Capital's AGTC Position: Q3 2022 in Review

Shay Capital sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2022, closing a stake of 50,000 shares — an estimated $39K sold.

Shay Capital first reported a position in AGTC in Q1 2022 and held it in 2 quarters. The position peaked at $54K in Q1 2022. 45 funds tracked by Wall St. Rank hold AGTC as of Q3 2022.

  • Shay Capital reported no remaining Applied Genetic Technologies Corporation position as of Q3 2022 after selling out during the quarter.
  • Shay Capital sold 50,000 Applied Genetic Technologies Corporation shares in Q3 2022, an estimated $39K.
  • Shay Capital first reported a position in Applied Genetic Technologies Corporation in Q1 2022 and held it in 2 quarters.
  • Shay Capital's Applied Genetic Technologies Corporation position peaked at $54K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2022.

Based on Shay Capital's 13F filing for Q3 2022, filed 14 Nov 2022.